Forum Posts

Jadumani Singh
Mar 12, 2022
In Webinars & Workshops
ECMO content media
0
0
4
Jadumani Singh
Feb 18, 2022
In Webinars & Workshops
Therapeutic Plasma Exchange in ICU content media
0
0
9
Jadumani Singh
Sep 20, 2021
In Digital Health
HotCase Programme app is to assist all intensive care trainees to enter and submit clinical cases as a part of formative assessment for the second part of the CICM exam in Australia and New Zealand. The clinical exam may be submitted to the Supervisor of Training (SoT) for review or saved as a file in the file folder or in the iCloud.
HotCase App content media
0
0
10
Jadumani Singh
Sep 20, 2021
In Digital Health
Simple tool to log your ICU procedures www.jranalytics.com/procedure-log
Procedure log content media
0
0
5
Jadumani Singh
Sep 20, 2021
Equipment and device used in ICU content media
0
0
4
Jadumani Singh
Sep 20, 2021
In Digital Health
20 Nov 2021 Webinar presentations www.jranalytics.com/presentations The ROTEM traces in the image shows an extended clotting time in EXTEM, FIBTEM, INTEM, and APTEM. When do you see such traces? (Hint: Patient is on an anticoagulant) www.jranalytics.com/presentations Introduction to ROTEM (27:28-28:23) Learn about ROTEM assays, parameters, interpretation through iTEM app. Download the free app from the app store https://apps.apple.com/au/app/item/id1573537854...
Interpreting TEM App content media
0
0
10
Jadumani Singh
Sep 20, 2021
In Webinars & Workshops
Do you know these lines seen on lung ultrasonography? www.jranalytics.com/presentations Bedside ECHO & USG in ICU- Shock, Fluid Responsiveness & Failure to wean 20 Nov 2021 Basic ultrasound head-to-toe skills for intensivists in the general and neuro intensive care unit population: consensus and expert recommendations of the European Society of Intensive Care Medicine https://link.springer.com/article/10.1007/s00134-021-06486-z?fbclid=IwAR1jxrC6V0kPA-VUNNaO3JyWV7fXzG7OvhLwh2NdHWwxaWTjbx6691bJmt
Bedside ECHO & USG in ICU content media
0
0
14
Jadumani Singh
Sep 20, 2021
In Webinars & Workshops
Watch an interview with Dr Anand Rao, an interventional cardiologist from Mumbai on World Heart Day. Dr Anand talks about risk factors, interventions, and outcomes in patients with cardiovascular disease especially patients with myocardial infarction (heart attack) With 18 years of experience in intervention cardiology, he is a practising physician at the Lilavati, Holy Family and PD Hinduja hospital. He is an expert in complex coronary interventions and has a special interest in bifurcation and left main interventions. He also specialises in intravascular imaging. Questions Q1 The diagnosis of MI may seem to be straightforward but what are the issues with an early diagnosis? Q2 As treatment delays are associated with worse outcomes, current guidelines recommend minimizing the time from symptom onset to treatment initiation. Can you tell us about the importance of early re-vascularization and how do you achieve it in your centre? Q3&4 How important is family history with cardiovascular disease, including diabetes and hypertension? How important are home bp and ambulatory bp monitoring? Can you also comment on diet, exercise and cooking oil? Q5 Exercise and sudden cardiac death, what’s the interpretation? Q6 Is lowering LDL cholesterol is the final nail in the coffin? Q7: What is the difference between PCI (Percutaneous Coronary Intervention) and POBA (plain old balloon angioplasty)? Q8: Based on your practice or literature- Primary angioplasty and pharmaco-invasive therapy… which is better or what’s the ground reality? Q9 In the western world, the introduction of the pre-hospital ECG has led to improved triage in the field, resulting in a more rapid preliminary diagnosis, the possibility to start early reperfusion therapy on the scene, and finally in the possibility to prepare the hospital for direct transport to catheterization laboratory and early PCI. Is this something in your practice too? What do you recommend in places with fewer resources to manage a situation like this? Q10 What are the recent advances in heart failure, in regards to newer drugs and devices? Q 11 Atrial fibrillation- How do we individualise this treatment- rate control, rhythm control or and/or ablation? Q12: What’s the current standing in non-surgical aortic valve replacement? How feasible is it in our context? Q13 What would you advise – about chest pain and how to recognize – when one is having a heart attack and when to consult a doctor or go to the hospital? Is young age a new risk factor in CAD?
Heart of the matter in cardiovascular disease content media
0
0
3

Jadumani Singh

Admin
More actions